Kalaris Therapeutics Inc (KLRS)
Kalaris Therapeutics Inc Statistics
Share Statistics
Kalaris Therapeutics Inc has 18.7M shares outstanding. The number of shares has increased by null% in one year.
| 18.7M |
| n/a |
| n/a |
| n/a |
| n/a |
| 3,592 |
| 7.89% |
Short Selling Information
The latest short interest is 70.57K, so 0% of the outstanding shares have been sold short.
| 70.57K |
| n/a |
| n/a |
| 1.51 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Kalaris Therapeutics Inc.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.
| 0.85 |
| 0.85 |
| 0 |
| n/a |
| n/a |
| -19.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,049,928.57 |
| 14 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Kalaris Therapeutics Inc's price volatility has been lower than the market average.
| 0 |
| n/a |
| 5.31 |
| n/a |
| 36.27 |
| 45,507 |
Balance Sheet
The company has 3.17M in cash and 0 in debt, giving a net cash position of 3.17M.
| 3.17M |
| n/a |
| n/a |
| -47.39M |
| n/a |
| n/a |
Cash Flow
In the last 12 months, operating cash flow was -14.13M and capital expenditures 0, giving a free cash flow of -14.13M.
| -14.13M |
| n/a |
| -14.13M |
| 0 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
KLRS does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jan 16, 2025. It was a backward split with a ratio of 1:23.
| Jan 16, 2025 |
| backward |
| 1:23 |
Scores
| n/a |
| n/a |